Elevance Health, Inc. (LON:0HG8)
London · Delayed Price · Currency is GBP · Price in USD 345.06
+1.11 (0.32%)
At close: Dec 19, 2025
Elevance Health Market Cap
Elevance Health has a market cap or net worth of 56.61 billion as of December 19, 2025. Its market cap has decreased by -22.43% in one year.
Market Cap
56.61B
Enterprise Value
74.20B
Revenue
144.93B
Ranking
n/a
PE Ratio
13.75
Stock Price
345.06
Market Cap Chart
Since October 30, 2001, Elevance Health's market cap has increased from 2.89B to 56.61B, an increase of 1,857.41%. That is a compound annual growth rate of 13.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 56.61B | -17.16% |
| Dec 31, 2024 | 68.34B | -21.43% |
| Dec 29, 2023 | 86.98B | -14.45% |
| Dec 30, 2022 | 101.68B | 22.37% |
| Dec 31, 2021 | 83.09B | 42.06% |
| Dec 31, 2020 | 58.49B | 1.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.09B |
| GSK plc | 72.73B |
| Haleon | 32.99B |
| Smith & Nephew | 10.46B |
| Convatec Group | 4.73B |
| Hikma Pharmaceuticals | 3.34B |
| HUTCHMED (China) | 1.75B |
| Genus | 1.74B |